SHEA YOUNG: Open Payments
NPI 1912161589 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,826 in 141 payments from 18 companies in 2025. Trend: 2023 $2,281 · 2024 $2,856 · 2025 $2,826
Food & beverage: $2,816Education: $10
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $279 |
| ABBVIE INC. | 13 | $277 |
| Novartis Pharmaceuticals Corporation | 8 | $275 |
| Arcutis Biotherapeutics, Inc. | 13 | $274 |
| UCB, Inc. | 14 | $266 |
| Incyte Corporation | 12 | $253 |
| GENZYME CORPORATION | 9 | $199 |
| Lilly USA, LLC | 10 | $190 |
| Regeneron Healthcare Solutions, Inc. | 12 | $188 |
| Galderma Laboratories, L.P. | 16 | $176 |
Products named: DUPIXENT, CIBINQO, Zoryve, Bimzelx, OPZELURA, RINVOQ, TALTZ, COSENTYX.
Industry payments across TX — which companies pay providers there.
